Dealings Round-Up

Director dealings: Roquefort Therapeutics director raises stake

By Iain Gilbert

Date: Monday 24 Nov 2025

(Sharecast News) - Roquefort Therapeutics revealed on Monday that interim managing director Darrin Disley had acquired 5.0m ordinary shares in the London-listed material biotech company.
Disley, who joined Roquefort in September 2022, purchased the shares on Friday at an average price of 1.70p each, for a total value of £85,000.

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page